Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitors
申请人:NUVATION BIO INC.
公开号:US11192900B2
公开(公告)日:2021-12-07
Novel bromodomain and extraterminal domain (BET) inhibitors contanining substituted 2-pyridones and therapeutic methods of treating conditions and diseases using these novel BET inhibitors are provided.
本研究提供了含有取代的 2-
吡啶酮的新型
溴结构域和外结构域(BET)
抑制剂,以及使用这些新型 BET
抑制剂治疗病症和疾病的方法。